drugset / Trial / NCT00846833
Haploidentical NK Cell Infusion in Malignant Melanoma
NaSingle-groupOpen-labelTreatment
Summary
We hypothesized that haploidentical NK cells kill tumor cells more efficiently than autologous NK cells, based on the missing-self hypothesis. Therefore, we performed this study to investigate the role of haploidentical NK cell therapy in patients with refractory or relapsed malignant melanoma.
Timeline
- Start
- 2009-02
- Primary completion
- 2011-02
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Haploidentical NK cell | Cell therapy | — | — |